Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
53 DAFTAR PUSTAKA Aguzzi A., Weissman C. 1997. Prion Research: The Frontiers. Nature, (389): 795-798 Anderson P. 1997. Kinases Cascade Regulating Entry Apoptosis. Microbiology and Molecular Biology, (6 1): 33-46 Baratawidjaja K. G. 2000. Imunologi Dasar. ed. Jakarta:Gaya Baru Block T.M., Hill J. M. 1997. The Latency Associated Transcript (LAT) of Herpes Simpleks Virus: Still No End in Site. Neurovirol, (3): 3 13-321 Chesebro B., Caughey B. 1997. Transmissible Spongiform Encephalopathies (Prion Protein Diseases). New York: ChurchillLivingstone Inc. P. 1287-1304 Cohen F.E., Prusiner S.B. 1998. Pathological Confrontation of Pion Proteins. Annual Reverence Biochemistry, (67): 8 11-819 Couceiro J. N. S. S., Kelm S., Baum L. G., Krauss S., Castrucci M.R., Donatelli L., et al. 1998. Molecular Basis For the Generation in Pigs of Influenza A Virus With Pandemic Potential. New York: Raven Press Flint S. J., Enquist L. W., Krug R. M., Racaniello V. R., Skalka A. M. 2000. Principles of Virology : Molecular Biology, Pathogenesis, and Control. Washington D. C .: ASM Press Farquhar C. F., Somerville R. A., Bruce M. E. Hypothesis. Nature, (39 1): 345--346 1998. Straining the Prion Fenner F. J., 1993, Veterinary Virology,Orlando:AcademicPress Inc. Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. 1995 Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege. Science, (270): 1189-1 192 Hedge R. S., Mastrianni J. A., Scott M. R. DeFea K. A., Tremblay P., TorchiaM., et al. 1998. A Transmembrane Form of The Prion Protein in Neurodegenerative Disease. Science, (279): 827-834 Karp C. L., Wysocka M., Wahl L. M., Ahearn P. J., Sherry B., Griffin D. E. 1996. Mechanism of Supression of Cell-Mehated Immunity by Measles Virus. Science, (272): 228-23 1 53 Levy J. A. 1998. HIV And the Pathogenesis of AIDS. ASM Press ed. WashingtonD.C.: Longnecker R., Miller C. L. 1996. Regulation of Epstein-Barr Latency by Latent Membrane Protein 2. Trends Microbiology, (4):38-42 Meulen T.V. 1994. Pathogenesis of Persistent Infections. Seminar of Yirology, ( 5 ) : 299-324 Miller L.K., white E. 1998. Apoptosis in Viral Infection. Seminar of Yirology, (8): 493-523 Mims C.A., Dimmock N., Nash A., Stephen A. 1995. Mim 's Pathogenesis of Infectious Diseases, ed. Orlando: Academic Press Richman D. D., Whitley R. J., Hayden F. G. 1996. Clinical Virology. New York: ChurchillLivingstone Inc. Reyburn H. T., Mandelboim O., Vales-Gomez M., Davis D. M., Pazmany L, Strominger J. L. 1997. The Class I MHC Homologue of Human Cytomegalovirus Inhibits Attack by Natular Killer Cells. Nature, (368): 5 14-517 Sawtell N. M. 1997. Comprehensive Quantification of Herpes Simplex Virus Latency at the Single Cell Level. Journal of Yirology, (7 1): 542-543 Spriggs M.K. 1996. One Step Ahead of The Game: Viral Immunomodulatory Molecules. Annual Reverence Immunology, (14): 101- 142 Wagner E. K. 1994. Herpesvirus Latency. Seminary of Virology, (5):198-203